Eli Lilly | Pharma Commons 2012-07-11 09:39:04

Eli Lilly's ($LLY) attempt to develop a new schizophrenia drug that skirts the serious side effects of Zyprexa--while replacing the blockbuster cash the pharma giant is losing to generic competition--…
Read the full story: News